Chronic obstructive pulmonary disease, or COPD, is one of the world’s leading causes of death, responsible for 3.5 million ...
As of early 2026, COPD remains the fifth-leading cause of death nationwide and carries a substantial economic burden, with ...
Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: ...
The American Lung Association today announced the launch of the COPD-OMA trial, a national clinical research effort conducted through its Airways Clinical Research Centers (ACRC). The study will ...
Could mobile technology help patients with chronic obstructive pulmonary disease (COPD) who may not seek care until they experience an exacerbation? A recent study found a wearable device and mobile ...
Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to improving the lives of people with chronic lung diseases including COPD and asthma, today announced the enrollment of the first ...
Nebuliser use in COPD is most common in severe disease with frequent exacerbations, high symptoms, and reduced lung function.
The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and advocacy organization. Founded in 1997 in collaboration with the U.S. National ...
Editor: COPD (Chronic Obstructive Pulmonary Disease) it is the third leading cause of death worldwide and the leading cause of disability. Early diagnosis is crucial. COPD affects an estimated 30 ...
Cardiovascular diseases and diabetes are some of the most common coexisting conditions in COPD. Shared risk factors and overlapping physiological processes likely contribute to the high rate of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results